Form 8-K - Current report:
SEC Accession No. 0001683168-25-000099
Filing Date
2025-01-06
Accepted
2025-01-06 07:05:08
Documents
19
Period of Report
2025-01-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k.htm   iXBRL 8-K 37977
2 OPINION OF CARROLL LEGAL LLC acon_ex0501.htm EX-5.1 12818
3 SECURITIES PURCHASE AGREEMENT acon_ex1001.htm EX-10.1 239523
4 PLACEMENT AGENCY AGREEMENT acon_ex1002.htm EX-1.1 194792
5 PRESS RELEASE acon_ex9901.htm EX-99.1 14534
10 GRAPHIC image_001.jpg GRAPHIC 11252
  Complete submission text file 0001683168-25-000099.txt   845962

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE acon-20250103.xsd EX-101.SCH 3788
7 XBRL DEFINITION FILE acon-20250103_def.xml EX-101.DEF 26648
8 XBRL LABEL FILE acon-20250103_lab.xml EX-101.LAB 36765
9 XBRL PRESENTATION FILE acon-20250103_pre.xml EX-101.PRE 25272
21 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 25509018
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)